Innovative Use of mHealth and Clinical Technology for Oncology Clinical Trials in Africa

• Published in: JCO global oncology 2020-06, Vol.6 (6), p.948-953
• Main Authors: Mutebi, Miriam, Bhatia, Rohini, Salako, Omolola, Rubagumya, Fidel, Grover, Surbhi, Hammad, Nazik
• Format: Article
• Language: English
• Subjects: REVIEW ARTICLES
• ISSN: 2687-8941; 2687-8941
• DOI: 10.1200/JGO.19.00191

Utilization of clinical technology and mobile health (mHealth) is expanding globally. It is important to reflect on how their usage and application could translate in low- and middle-income country (LMIC) settings. With the exponential growth and advancements of mobile and wireless technologies, LMICs are prime to adapt such technologies to potentially democratize and create solutions to health-related challenges. The role of these technologies in oncology clinical trials continues to expand. The lure of mHealth promises disruptive technology that may change the way clinical trials are designed and conducted in many settings. Its applicability in the African context is currently under consideration. Although potentially of expanding benefit, the role of these technologies requires careful and nuanced evaluation of the context in which they might be applied to harness their full potential, while mitigating possible harms or preventing further deepening of disparities within populations. Moreover, technology and digital innovations are no substitute for poor referral pathways and dysfunctional health systems and can only complement or enhance definite strategies aimed at strengthening these health systems.